Gossamer Bio Inc (GOSS)

Gossamer Bio (GOSS) Stock Price & Analysis


GOSS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.91 - $15.20
Previous Close$1.21
Average Volume (3M)2.99M
Market Cap
Enterprise Value-$61.94M
Total Cash (Recent Filing)$201.86M
Total Debt (Recent Filing)$23.48M
Price to Earnings (P/E)-0.5
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.50
Shares Outstanding95,444,095
10 Day Avg. Volume1,885,949
30 Day Avg. Volume2,989,853
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)-4.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.30
Price Target Upside288.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Gossamer Bio Inc’s price range in the past 12 months?
Gossamer Bio Inc lowest stock price was $0.91 and its highest was $15.20 in the past 12 months.
    What is Gossamer Bio Inc’s market cap?
    Currently, no data Available
    When is Gossamer Bio Inc’s upcoming earnings report date?
    Gossamer Bio Inc’s upcoming earnings report date is Aug 09, 2023 which is in 62 days.
      How were Gossamer Bio Inc’s earnings last quarter?
      Gossamer Bio Inc released its earnings results on May 09, 2023. The company reported -$0.52 earnings per share for the quarter, beating the consensus estimate of -$0.53 by $0.01.
        Is Gossamer Bio Inc overvalued?
        According to Wall Street analysts Gossamer Bio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Gossamer Bio Inc pay dividends?
          Gossamer Bio Inc does not currently pay dividends.
          What is Gossamer Bio Inc’s EPS estimate?
          Gossamer Bio Inc’s EPS estimate is -$0.5.
            How many shares outstanding does Gossamer Bio Inc have?
            Gossamer Bio Inc has 95,444,090 shares outstanding.
              What happened to Gossamer Bio Inc’s price movement after its last earnings report?
              Gossamer Bio Inc reported an EPS of -$0.52 in its last earnings report, beating expectations of -$0.53. Following the earnings report the stock price went up 3.676%.
                Which hedge fund is a major shareholder of Gossamer Bio Inc?
                Among the largest hedge funds holding Gossamer Bio Inc’s share is Platinum Investment Management. It holds Gossamer Bio Inc’s shares valued at 3M.


                  Gossamer Bio Stock Smart Score

                  The Gossamer Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Gossamer Bio Inc

                  Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate is GB001, which is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.


                  Top 5 ETFs holding GOSS

                  Market Value
                  Smart Score
                  iShares Biotechnology ETF
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  iShares Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold GOSS. The ETFs are listed according to market value of GOSS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Bioxcel Therapeutics
                  G1 Therapeutics
                  Eton Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis